A special European Journal of Rheumatology issue on systemic sclerosis: What and why?
作者信息
Del Galdo Francesco, Matucci-Cerinic Marco
机构信息
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom.
NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust Leeds, Leeds, United Kingdom.
出版信息
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S137-S138. doi: 10.5152/eurjrheum.2020.090121. Epub 2020 Oct 1.
Abstract
摘要
相似文献
1
A special European Journal of Rheumatology issue on systemic sclerosis: What and why?《欧洲风湿病学杂志》关于系统性硬化症的一期特刊：内容与缘由？
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S137-S138. doi: 10.5152/eurjrheum.2020.090121. Epub 2020 Oct 1.
2
Pediatric rheumatology: A special issue from the European Journal of Rheumatology.儿科风湿病学：《欧洲风湿病学杂志》特刊
Eur J Rheumatol. 2020 Feb;7(Suppl1):S1-S2. doi: 10.5152/eurjrheum.2020.090120.
3
Systemic sclerosis associated respiratory involvement: Scopus-based analysis of articles in 2013-2022.系统性硬皮病相关的呼吸系统受累：基于 Scopus 的 2013-2022 年文献分析。
Rheumatol Int. 2024 Apr;44(4):693-702. doi: 10.1007/s00296-024-05535-2. Epub 2024 Feb 6.
4
Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease.2013年美国风湿病学会/欧洲抗风湿病联盟系统性硬化症（SSc）分类标准在大型、明确界定的SSc和混合性结缔组织病队列中的表现。
J Rheumatol. 2015 Jan;42(1):60-3. doi: 10.3899/jrheum.140047. Epub 2014 Oct 1.
5
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire.系统性硬化症患者报告结局指标的开发与验证：欧洲抗风湿病联盟系统性硬化症疾病影响（ScleroID）问卷
Ann Rheum Dis. 2022 Apr;81(4):507-515. doi: 10.1136/annrheumdis-2021-220702. Epub 2021 Nov 25.
6
Canadian Rheumatology Association Meeting Quebec City Convention Centre Quebec City, Quebec, Canada February 8-11, 2023.2023 年 2 月 8 日至 11 日，加拿大风湿病学会会议，魁北克市会议中心，魁北克市，加拿大。
J Rheumatol. 2023 Jul;50(7 Suppl 1):7-100. doi: 10.3899/jrheum.2023-0216. Epub 2023 Jun 1.
7
The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis.欧洲儿科风湿病学会/美国风湿病学会/欧洲抗风湿病联盟青少年系统性硬化症临时分类标准
Arthritis Rheum. 2007 Mar 15;57(2):203-12. doi: 10.1002/art.22551.
8
Monoliths: special issue in a new package.巨石：新套餐中的特辑。
J Sep Sci. 2013 Aug;36(16):i-ii. doi: 10.1002/jssc.201370153.
9
New-Onset Salt-and-Pepper Skin Changes Associated With Vaccination and Trauma in Systemic Sclerosis: Immunity Matters.系统性硬化症中与疫苗接种和创伤相关的新发椒盐样皮肤改变：免疫起关键作用。
J Rheumatol. 2022 Aug 15. doi: 10.3899/jrheum.220553.
10
Review for best practice in clinical rheumatology juvenile systemic sclerosis - Updates and practice points.临床风湿病学幼年系统性硬皮病最佳实践复习 - 更新和实践要点。
Best Pract Res Clin Rheumatol. 2021 Sep;35(3):101688. doi: 10.1016/j.berh.2021.101688. Epub 2021 Apr 22.
本文引用的文献
1
The burning question: To use or not to use cyclophosphamide in systemic sclerosis.亟待解决的问题：系统性硬化症中是否使用环磷酰胺。
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S237-S241. doi: 10.5152/eurjrheum.2020.19104. Epub 2020 Oct 1.
2
Systemic sclerosis: To subset or not to subset, that is the question.系统性硬化症：是否进行亚组分析，这是个问题。
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S222-S227. doi: 10.5152/eurjrheum.2020.19116. Epub 2020 Jul 6.
3
New perspectives in the imaging of Raynaud's phenomenon.雷诺现象影像学的新视角。
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S212-S221. doi: 10.5152/eurjrheum.2020.19124. Epub 2020 Jul 6.
4
Screening for pulmonary arterial hypertension in systemic sclerosis: Now or never!系统性硬化症中肺动脉高压的筛查：机不可失！
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S187-S192. doi: 10.5152/eurjrheum.2020.19114. Epub 2020 Oct 1.
5
Putative functional pathogenic autoantibodies in systemic sclerosis.系统性硬化症中假定的功能性致病性自身抗体。
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S181-S186. doi: 10.5152/eurjrheum.2020.19131. Epub 2020 Oct 1.
6
Molecular "omic" signatures in systemic sclerosis.系统性硬化症中的分子“组学”特征
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S173-S180. doi: 10.5152/eurjrheum.2020.19192. Epub 2020 Oct 1.
7
Role of adipokines in systemic sclerosis pathogenesis.脂肪因子在系统性硬化症发病机制中的作用。
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S165-S172. doi: 10.5152/eurjrheum.2020.19107. Epub 2020 Jul 6.
8
Epigenetics and systemic sclerosis: An answer to disease onset and evolution?表观遗传学与系统性硬化症：疾病发生与演变的答案？
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S147-S156. doi: 10.5152/eurjrheum.2020.19112. Epub 2020 Jul 20.
9
News and failures from recent treatment trials in systemic sclerosis.系统性硬化症近期治疗试验的相关新闻与失败案例。
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S242-S248. doi: 10.5152/eurjrheum.2020.19187. Epub 2020 Jul 20.
10
Biomarkers as an opportunity to stratify for outcome in systemic sclerosis.生物标志物作为系统性硬化症预后分层的一个契机。
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S193-S202. doi: 10.5152/eurjrheum.2020.19065. Epub 2020 Jul 20.
Zotero 插件